Sep 16, 2020 — Accelerate Diagnostics today announced that the Company has received U.S. Food and Drug Administration (FDA) clearance for a new suite of product enhancements to the Accelerate Pheno® system to improve performance and expand the system’s antimicrobial susceptibility testing (AST) menu for bloodstream infections. The new release features improvements in susceptibility testing performance for four important […]
Accelerate Diagnostics Announces FDA Emergency Use Authorization for COVID-19 Individual IgM and IgG Antibody Tests
Sep 10, 2020 — Accelerate Diagnostics and BioCheck, Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the individual BioCheck SARS-CoV-2 IgM Test Kit and the BioCheck SARS-CoV-2 IgG Test Kit. Today’s announcement follows the recent EUA approval of the fully automated MS-Fast instrument and the BioCheck SARS-CoV-2 IgM […]
Arizona Daily Star Covers New COVID-19 Tests from Accelerate Diagnostics
Sep 03, 2020 — In an article released today, the Arizona Daily Star/Tucson.com covers the new COVID-19 testing solution offered by Accelerate Diagnostics under FDA Emergency Use Authorization. Read the full story here.
Accelerate Diagnostics Names Nedal Safwat Chief Strategy Officer
Aug 24, 2020 — Accelerate Diagnostics today announced that Nedal Safwat has been appointed its Chief Strategy Officer. Dr. Safwat has over 20 years of experience in the medical device, in vitro diagnostics, and life sciences industries. He previously served as the Executive Director of the ID/AST Franchise at bioMerieux.joins Accelerate from BioMerieux, where he served in multiple roles […]
See all news
Enter your email address below for access to photos, logos and videos.
Connect with us
Want to hear when we announce our next event? Stay up to date with Accelerate by joining our mailing list.Sign up today
February 3-6, 2020
Dubai World Trade Centre, UAE
December 16-17, 2019
Palais des Congrès de Paris, France
December 4-6 2019
Hamburg Messe, Germany
November 11-14, 2019
November 9-12, 2019
Palacongressi Di Rimini, IT
October 2-6, 2019
Over the past several years, Accelerate Diagnostics, together with our scientific collaborators, conducted numerous scientific studies supporting the exciting capabilities of our ID/AST System. Many of these studies resulted in posters presented at international conferences and peer-reviewed publications. We have conducted over 87,000 internal identification and susceptibility experiments across a panel of more than 20 of the most clinically prevalent species in sample types such as positive blood cultures and BALs. These studies demonstrated compelling performance versus reference and comparator methods, the results of which have been consistently duplicated by our clinical research partners. Below you will find links to some of these posters and publications.
These publications may include information from one or more organism/antimicrobial combinations that are research use only and not for use in diagnostic procedures.
Certain uses of devices included in these publications may not have been approved or cleared by the U.S. Food and Drug Administration or other regulatory bodies.
See product labeling for instructions for use, warnings, and limitations specific to each product and region.Okay, I understand. Show me the publications.